Better Therapeutics, Inc.

BTTX · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$39,760-$40,335-$6,387-$5,784
Dep. & Amort.$2,729$1,619$75$72
Deferred Tax$0-$152$152$1
Stock-Based Comp.$1,824$646$233$84
Change in WC$6,268-$2,339$306-$589
Other Non-Cash$9$9,743-$153-$1
Operating Cash Flow-$28,930-$30,818-$5,774-$6,217
Investing Activities
PP&E Inv.-$106-$1,071-$2,305-$2,736
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1,074$0$0$0
Investing Cash Flow-$1,180-$1,071-$2,305-$2,736
Financing Activities
Debt Repay.$5,000$28,675$3,650$5,000
Stock Issued$284-$14,870$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$58,527$3,795$3,700
Financing Cash Flow$5,284$72,332$7,445$8,700
Forex Effect$0$0$0$0
Net Chg. in Cash-$24,826$40,443-$634-$253
Supplemental Information
Beg. Cash$40,566$123$757$1,010
End Cash$15,740$40,566$123$757
Free Cash Flow-$30,110-$31,889-$8,079-$8,953